The Calamos Phineus Long/Short Fund (CPLIX) team managed by Michael Grant, Co-CIO, Head of Long/Short Strategies, and Senior Co-Portfolio Manager, has battled and won more days than the broad market, resulting in CPLIX’s year-to-date return of -1.65% versus the S&P’s loss of -16.14% as of Aug. 30. That’s a 1449 basis point outperformance.
Read PostThe economy’s continued reopening and an eventual fiscal package will support demand while cost cuts will drive operating leverage. These two should be a powerful combination to support earnings growth into 2021, says Michael Grant, Co-CIO, Senior Co-Portfolio Manager and Head of Long/Short Strategies.
Read PostThe Calamos investment team makes the case for additional market upside—while cautioning investors to prepare for turbulence.
Read PostAfter all the market optimism expressed in August, the September 3-8 pullback provided a reminder that equities can surprise and disappoint. We have a few ideas for managing the risks.
Read Post"What do we see ahead? Investment professionals are invited to join a series of conference calls with the Calamos Investment Management team providing perspectives on their respective domains, including U.S. and international equities, liquid alternatives, and fixed income."
Read PostCalamos Market Neutral Income Fund (CMNIX) is the largest alternative in Morningstar’s $142 billion Alternative Funds category as of 8/31/19, according to Morningstar data. Calamos is the third largest liquid alts provider based on AUM.
Read PostThese are the markets our alternative funds are made for, an opportunity to demonstrate why they’re worthy of financial advisors' consideration as a core allocation in clients’ portfolios.
Read PostDays away from the start of the fourth quarter of 2017, Calamos long/short portfolio manager Michael Grant says he expects equities to move higher.
Read PostInvestor allocations to cash reflects the discomfort with the stock market. But for the long-term investor, cash may not serve their best interests.
Read Post
